Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 XOMA, Schering-Plough Extend Antibody Collaboration | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

XOMA, Schering-Plough Extend Antibody Collaboration

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Schering-Plough has exercised its right to initiate additional discovery and development programs under its collaboration with XOMA, Ltd. for therapeutic antibody products. XOMA received up-front payments for each additional program and will receive research funding for each project as well as success based milestones and royalties on any product sales that result from the collaboration.

“We have made significant progress on the first product program since its initiation with Schering-Plough in mid-2006,” said Jack Castello, chairman of the board, president, and chief executive officer of XOMA. “We look forward to advancing the new programs in a similar high quality and expedited manner.”

Under the initial collaboration, XOMA was responsible for discovering therapeutic antibodies against multiple targets selected by Schering-Plough. Other XOMA activities may include preclinical studies to support regulatory filings, cell line and process development, and production of antibodies for initial clinical trials.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics